Inactive Instrument

Other languages Aastrom Biosciences Inc Nasdaq

Equities

US00253U4040

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	Apr. 19
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	Mar. 15
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	Mar. 13
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	Mar. 11
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	Feb. 29
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	Feb. 29
Vericel Insider Sold Shares Worth $1,677,200, According to a Recent SEC Filing	Feb. 16
Vericel Insider Sold Shares Worth $334,775, According to a Recent SEC Filing	Jan. 24
Vericel Insider Sold Shares Worth $1,280,375, According to a Recent SEC Filing	Jan. 19
Vericel Corporation Provides Earnings Guidance for the Year 2024	Jan. 10
Vericel Reports Q4 Preliminary Unaudited Revenue; Shares Rise	Jan. 09
Vericel Corporation Provides Earnings Guidance for the Fourth Quarter and Full-Year 2023	Jan. 09
Vericel Insider Sold Shares Worth $853,800, According to a Recent SEC Filing	Dec. 15
Vericel Insider Sold Shares Worth $832,909, According to a Recent SEC Filing	Dec. 08
Vericel Insider Sold Shares Worth $617,798, According to a Recent SEC Filing	Dec. 01
Vericel Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Vericel Corporation Provides Total Net Revenue Guidance for 2023	Nov. 08
Vericel Corporation Announces U.S. Commercial Availability of NexoBrid (Anacaulase-Bbb) for the Treatment of Severe Thermal Burns in Adults	23-09-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aastrom Biosciences Inc Nasdaq

Equities

US00253U4040

Other languages

Filters